{"product_id":"2021-pathology-review-gynecologic-breast-and-soft-tissue-for-the-general-pathologist","title":"2021 Pathology Review: Gynecologic, Breast and Soft Tissue for the General Pathologist","description":"\u003cp\u003e[\u003c\/p\u003e\n\u003ch3\u003e2021 Pathology Review: Gynecologic, Breast and Soft Tissue for the General Pathologist\u003c\/h3\u003e\n\u003cdiv id=\"tab-description\" class=\"woocommerce-Tabs-panel woocommerce-Tabs-panel--description panel entry-content active\" role=\"tabpanel\" aria-labelledby=\"tab-title-description\"\u003e\n\u003cdiv class=\"tab-panels\"\u003e\n\u003cdiv id=\"tab-description\" class=\"panel entry-content active\"\u003e\n\u003ch4\u003e\u003cstrong\u003eEducational Objectives :\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cstrong\u003eAt the completion of this CME teaching activity, you should be able to:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e Discuss the challenges radiologists face when caring for a pediatric patient.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eDifferentiate serous, endometrial and sex cord tumors of the gynecologic track.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003e Discuss the challenges associated with cervical lesions of the uterus.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003e Achieve a better understanding of practical placental pathology.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003e Identify inflammatory and reactive lesions of the breast.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003e Achieve a greater understanding of problematic issues in breast core needle biopsies.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003e Analyze post-neoadjuvant breast specimens.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003e Identify spindle cell and vascular tumors of the breast.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003e Discuss the recent updates to the ER\/PR and HER2 testing guidelines.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003e Apply molecular testing in the management of breast cancer.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003e Achieve a better understanding of mesenchymal tumors of the uterus.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003e Review problematic in situ lesions of the breast.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eAchieve a better understanding of the challenges associated with melanocytic lesions in the pediatric population.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003e Discuss the continuing dilemma of ductal carcinoma in situ.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003e Review pseudolymphomas.\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003e\u003cstrong\u003eProgram :\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cstrong\u003eSerous Neoplasia of the Ovary\u003c\/strong\u003e\u003cbr\u003e\n\u003cstrong\u003eMara H. Rendi, M.D., Ph.D.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEndometrial Neoplasia, Subtypes, Mimics and Molecular Testing\u003c\/strong\u003e\u003cbr\u003e\n\u003cstrong\u003eMara H. Rendi, M.D., Ph.D.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSex Cord Stromal Tumors of the Gynecologic Track\u003c\/strong\u003e\u003cbr\u003e\n\u003cstrong\u003eMara H. Rendi, M.D., Ph.D.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eProblematic Issues in Breast Core Needle Biopsies\u003c\/strong\u003e\u003cbr\u003e\n\u003cstrong\u003eStuart J. Schnitt, M.D.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eInflammatory and Reactive Lesions of the Breast\u003c\/strong\u003e\u003cbr\u003e\n\u003cstrong\u003eStuart J. Schnitt, M.D.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEvaluation of the Post-Neoadjuvant Chemotherapy Breast Specimen\u003c\/strong\u003e\u003cbr\u003e\n\u003cstrong\u003eStuart J. Schnitt, M.D.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eThe Spectrum of Triple Negative Breast Cancer\u003c\/strong\u003e\u003cbr\u003e\n\u003cstrong\u003eStuart J. Schnitt, M.D.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePseudolymphomas\u003c\/strong\u003e\u003cbr\u003e\n\u003cstrong\u003eAlejandro Ariel Gru, M.D.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eUpdate in Cutaneous Lymphomas in the WHO Classification\u003c\/strong\u003e\u003cbr\u003e\n\u003cstrong\u003eAlejandro Ariel Gru, M.D.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSuperficial Mesenchymal Tumors in the Pediatric Setting\u003c\/strong\u003e\u003cbr\u003e\n\u003cstrong\u003eAlejandro Ariel Gru, M.D.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCutaneous Histiocytic Neoplasms\u003c\/strong\u003e\u003cbr\u003e\n\u003cstrong\u003eAlejandro Ariel Gru, M.D.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eThe Challenging Melanocytic Lesions in the Pediatric Population\u003c\/strong\u003e\u003cbr\u003e\n\u003cstrong\u003eAlejandro Ariel Gru, M.D.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eChallenging Cervical Lesions of the Uterus\u003c\/strong\u003e\u003cbr\u003e\n\u003cstrong\u003eMara H. Rendi, M.D., Ph.D.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMesenchymal Tumors of the Uterus\u003c\/strong\u003e\u003cbr\u003e\n\u003cstrong\u003eMara H. Rendi, M.D., Ph.D.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePractical Placental Pathology\u003c\/strong\u003e\u003cbr\u003e\n\u003cstrong\u003eMara H. Rendi, M.D., Ph.D.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eProblematic In Situ Lesions of the Breast\u003c\/strong\u003e\u003cbr\u003e\n\u003cstrong\u003eStuart J. Schnitt, M.D.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSpindle Cell and Vascular Lesions of the Breast\u003c\/strong\u003e\u003cbr\u003e\n\u003cstrong\u003eStuart J. Schnitt, M.D.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eThe Continuing Dilemma of Ductal Carcinoma in Situ\u003c\/strong\u003e\u003cbr\u003e\n\u003cstrong\u003eStuart J. Schnitt, M.D.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMolecular Testing \u0026amp; ER\/PR, HER2 Guidelines in the Management of Patients with Breast Cancer\u003c\/strong\u003e\u003cbr\u003e\n\u003cstrong\u003eStuart J. Schnitt, M.D.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003e]\u003c\/p\u003e\n\u003c\/div\u003e\n","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954650320994,"sku":"MED-AMB07536","price":50.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/2021-Pathology-Review-Gynecologic-Breast-and-Soft-Tissue-for-the.jpg?v=1779381644","url":"https:\/\/meducourse.com\/products\/2021-pathology-review-gynecologic-breast-and-soft-tissue-for-the-general-pathologist","provider":"Meducourse","version":"1.0","type":"link"}